No-reflow is one of the major causes of postinterventional rise of cardiac enzyme and
myocardial infarction (MI). This complication is associated with substantial morbidity and …

The no reflow phenomenon can happen during elective or primary percutaneous coronary
intervention. This phenomenon is thought to be a complex process involving multiple factors …

The no reflow phenomenon is reported to occur in> 2% of all percutaneous coronary
interventions (PCIs) and portends a poor prognosis. We analyzed data from 5,286 …

Objectives: This study was designed to investigate the influence of high dose intracoronary
adenosine on persistent ST‐segment elevation after primary percutaneous coronary …

Background and Objectives There is limited information on the transient or persistent no
reflow phenomenon in patients with acute myocardial infarction (AMI) undergoing …

Purpose It has been known that inflammatory mechanisms play an important role in the
coronary artery disease. Our aim in this study was to investigate the relationship between …

The coronary microcirculation regulates blood flow by responding to increased cardiac
metabolic demands. Despite this important role, study of the microcirculation has been …

No-reflow during percutaneous coronary intervention (PCI) is observed most commonly
during saphenous vein graft intervention, rotational atherectomy and primary PCI for acute …

There is increasing awareness that health screening may prevent some acute coronary
events. Yet, obstructive sleep apnea (OSA) is seldom screened for and its relation with …

A high proportion of primary percutaneous coronary interventions performed in the setting of
acute myocardial infarction, concur with inadequate myocardial perfusion at the …